These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11958443)

  • 1. Wearable defibrillator.
    Schott R
    J Cardiovasc Nurs; 2002 Apr; 16(3):44-52. PubMed ID: 11958443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The wearable cardioverter-defibrillator: current technology and evolving indications.
    Reek S; Burri H; Roberts PR; Perings C; Epstein AE; Klein HU; ; Lip G; Gorenek B; Sticherling C; Fauchier L; Goette A; Jung W; Vos MA; Brignole M; Elsner C; Dan GA; Marin F; Boriani G; Lane D; Blomström-Lundqvist C; Savelieva I
    Europace; 2017 Mar; 19(3):335-345. PubMed ID: 27702851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automatic external defibrillator, life vest defibrillator, or both?
    Richard Conti C
    Clin Cardiol; 2010 Dec; 33(12):722-3. PubMed ID: 21184554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the Wearable Cardioverter Defibrillator as a Bridge to Implantable Cardioverter Defibrillator.
    Weinstock J
    Card Electrophysiol Clin; 2018 Mar; 10(1):11-16. PubMed ID: 29428131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defibrillator indications and implantation in young children.
    Berul CI
    Heart Rhythm; 2008 Dec; 5(12):1755-7. PubMed ID: 18835225
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
    Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
    Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten advances defining sudden cardiac death.
    Mitrani RD; Myerburg RJ
    Trends Cardiovasc Med; 2016 Jan; 26(1):23-33. PubMed ID: 25957808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment.
    Technol Eval Cent Assess Program Exec Summ; 2010 Nov; 25(2):1-5. PubMed ID: 21638938
    [No Abstract]   [Full Text] [Related]  

  • 10. Saving lives and reducing inappropriate device therapy: the MADIT family of implantable cardioverter-defibrillator and cardiac resynchronization therapy trials.
    Moss AJ
    Cardiol J; 2013; 20(3):217-9. PubMed ID: 23788293
    [No Abstract]   [Full Text] [Related]  

  • 11. The evolution and revolution of the implantable cardioverter defibrillator.
    Indik JH
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):461-4. PubMed ID: 15225105
    [No Abstract]   [Full Text] [Related]  

  • 12. Will imaging assist in the selection of patients with heart failure for an ICD?
    Gerson MC; Abdallah M; Muth JN; Costea AI
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):101-10. PubMed ID: 20129539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.
    Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S
    Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter-defibrillator lead failure: how weak is the link?
    Brinker JA
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):758-9. PubMed ID: 18838965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. End-of-life of implantable defibrillator: are we certain it should always be replaced?
    Stazi F
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e116-e119. PubMed ID: 29538158
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of the wearable cardioverter defibrillator in clinical practice.
    Chung MK
    Cardiol Clin; 2014 May; 32(2):253-70. PubMed ID: 24793801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wearable Cardioverter Defibrillator "The Lifevest": Device Design, Limitations, and Areas of Improvement.
    Agarwal M; Narcisse D; Khouzam N; Khouzam RN
    Curr Probl Cardiol; 2018 Feb; 43(2):45-55. PubMed ID: 29277221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of amiodarone in the era of the implantable cardioverter defibrillator.
    Dorian P; Mangat I
    J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S78-81. PubMed ID: 12950525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The implantable defibrillator-cardioverter in the treatment of malignant ventricular arrhythmias].
    González-Hermosillo JA; Colín L; Iturralde P; Romero L
    Arch Inst Cardiol Mex; 1992; 62(3):197-202. PubMed ID: 1632710
    [No Abstract]   [Full Text] [Related]  

  • 20. MY APPROACH to early repolarization syndrome.
    Yan GX
    Trends Cardiovasc Med; 2016 May; 26(4):393-4. PubMed ID: 26944231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.